Clinical trial
Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients…
NCT00236951 · American Regent, Inc., Industry · Completed
Key facts
| NCT number | NCT00236951 |
|---|---|
| Title | Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy |
| Official title | A Phase III Randomized Controlled Study Comparing Iron Sucrose Intravenously to No Iron Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy |
| Lead sponsor | American Regent, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | iron sucrose injection USP, stable erythropoietin therapy |
| Enrollment | 224 |
| Start date | Feb 1, 2003 |
| Primary completion | Oct 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Oct 12, 2005 |
| Last update posted | Feb 20, 2018 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: